Annual Shareholders Equity
$21.72 M
-$4.99 M-18.69%
31 December 2023
Summary:
Silence Therapeutics annual stockholders equity is currently $21.72 million, with the most recent change of -$4.99 million (-18.69%) on 31 December 2023. During the last 3 years, it has risen by +$10.21 million (+88.75%). SLN annual shareholders equity is now -75.74% below its all-time high of $89.52 million, reached on 31 December 2015.SLN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$126.48 M
-$15.82 M-11.12%
01 September 2024
Summary:
Silence Therapeutics quarterly stockholders equity is currently $126.48 million, with the most recent change of -$15.82 million (-11.12%) on 01 September 2024. Over the past year, it has increased by +$104.76 million (+482.32%). SLN quarterly shareholders equity is now -19.14% below its all-time high of $156.43 million, reached on 31 March 2024.SLN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +482.3% |
| 3 y3 years | +88.8% | +999.2% |
| 5 y5 years | -20.8% | +361.4% |
SLN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.7% | +88.8% | -19.1% | +2300.0% |
| 5 y | 5 years | -20.8% | +88.8% | -19.1% | +2300.0% |
| alltime | all time | -75.7% | +407.1% | -19.1% | +2300.0% |
Silence Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $126.48 M(-11.1%) |
| June 2024 | - | $142.30 M(-9.0%) |
| Mar 2024 | - | $156.43 M(+620.2%) |
| Dec 2023 | $21.72 M(-18.7%) | $21.72 M(-11.0%) |
| Sept 2023 | - | $24.40 M(+57.8%) |
| June 2023 | - | $15.46 M(-24.8%) |
| Mar 2023 | - | $20.55 M(-23.1%) |
| Dec 2022 | $26.71 M(+132.1%) | $26.71 M(-29.9%) |
| Sept 2022 | - | $38.11 M(-763.0%) |
| June 2022 | - | -$5.75 M(-209.7%) |
| Mar 2022 | - | $5.24 M(-54.5%) |
| Dec 2021 | $11.51 M(-6.8%) | $11.51 M(-47.6%) |
| Sept 2021 | - | $21.97 M(-32.9%) |
| June 2021 | - | $32.76 M(+165.3%) |
| Dec 2020 | $12.35 M(-55.0%) | $12.35 M(-63.7%) |
| June 2020 | - | $34.00 M(+24.0%) |
| Dec 2019 | $27.42 M(-38.4%) | - |
| Dec 2019 | - | $27.42 M(-20.3%) |
| June 2019 | - | $34.42 M(-22.6%) |
| Dec 2018 | $44.48 M(-37.1%) | - |
| Dec 2018 | - | $44.48 M(-22.6%) |
| June 2018 | - | $57.47 M(-18.8%) |
| Dec 2017 | $70.75 M(+6.3%) | - |
| Dec 2017 | - | $70.75 M(+12.0%) |
| June 2017 | - | $63.15 M(-5.1%) |
| Dec 2016 | $66.57 M(-25.6%) | - |
| Dec 2016 | - | $66.57 M(-14.0%) |
| June 2016 | - | $77.36 M(-13.6%) |
| Dec 2015 | $89.52 M(+107.2%) | - |
| Dec 2015 | - | $89.52 M(-8.3%) |
| June 2015 | - | $97.60 M(+125.9%) |
| Dec 2014 | $43.20 M(-5.0%) | - |
| Dec 2014 | - | $43.20 M(-23.4%) |
| June 2014 | - | $56.42 M(+24.1%) |
| Dec 2013 | $45.47 M(+74.6%) | - |
| Dec 2013 | - | $45.47 M(-8.2%) |
| June 2013 | - | $49.52 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $26.04 M(-47.5%) | - |
| Dec 2012 | - | $26.04 M(+108.1%) |
| June 2012 | - | $12.51 M(-74.8%) |
| Dec 2011 | $49.58 M(-0.5%) | - |
| Dec 2011 | - | $49.58 M(-10.2%) |
| June 2011 | - | $55.23 M(+10.9%) |
| Dec 2010 | $49.80 M(+246.4%) | - |
| Dec 2010 | - | $49.80 M(-3.3%) |
| June 2010 | - | $51.52 M(+258.4%) |
| Dec 2009 | $14.38 M(-27.0%) | - |
| Dec 2009 | - | $14.38 M(-25.9%) |
| June 2009 | - | $19.40 M(-1.4%) |
| Dec 2008 | $19.69 M(-43.9%) | - |
| Dec 2008 | - | $19.69 M(-30.6%) |
| June 2008 | - | $28.36 M(-19.2%) |
| Dec 2007 | $35.11 M(+14.1%) | - |
| Dec 2007 | - | $35.11 M(+36.7%) |
| June 2007 | - | $25.69 M(-16.5%) |
| Dec 2006 | $30.76 M(+14.0%) | - |
| Dec 2006 | - | $30.76 M(+19.7%) |
| June 2006 | - | $25.69 M(-4.8%) |
| Dec 2005 | $26.98 M(+499.7%) | - |
| Dec 2005 | - | $26.98 M(+828.6%) |
| June 2005 | - | $2.91 M(-35.4%) |
| Dec 2004 | $4.50 M(-51.5%) | - |
| Dec 2004 | - | $4.50 M(-26.9%) |
| June 2004 | - | $6.16 M(-33.6%) |
| Dec 2003 | $9.27 M(-22.9%) | - |
| Dec 2003 | - | $9.27 M(-8.0%) |
| June 2003 | - | $10.07 M |
| Dec 2002 | $12.03 M(-7.2%) | - |
| Dec 2001 | $12.96 M(-22.0%) | - |
| Dec 2000 | $16.61 M(+11.6%) | - |
| Dec 1999 | $14.88 M(+169.0%) | - |
| Dec 1998 | $5.53 M(-27.9%) | - |
| Dec 1997 | $7.67 M(-29.3%) | - |
| Dec 1996 | $10.86 M(+153.5%) | - |
| Dec 1995 | $4.28 M | - |
FAQ
- What is Silence Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Silence Therapeutics?
- What is Silence Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Silence Therapeutics?
- What is Silence Therapeutics quarterly shareholders equity year-on-year change?
What is Silence Therapeutics annual stockholders equity?
The current annual shareholders equity of SLN is $21.72 M
What is the all time high annual shareholders equity for Silence Therapeutics?
Silence Therapeutics all-time high annual stockholders equity is $89.52 M
What is Silence Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SLN is $126.48 M
What is the all time high quarterly shareholders equity for Silence Therapeutics?
Silence Therapeutics all-time high quarterly stockholders equity is $156.43 M
What is Silence Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SLN quarterly stockholders equity has changed by +$104.76 M (+482.32%)